Insider · CIK 0001742485

Kumar Neil

CIK 0001742485 Name as filed on the most recent filing

Filed as Kumar Neil (55)

224 transaction lines · from 55 filings · filed 2018-06-22 to 2026-08-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

224 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-02-25 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,253,524, disposed Open Form 4 filing 0000950170-25-029228
2025-02-19 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 1,140,024, disposed Open Form 4 filing 0000950170-25-023625
2025-01-29 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 9,925,269, disposed Open Form 4 filing 0000950170-25-011239
2025-01-28 S, Open-market sale BridgeBio Pharma, Inc.BBIO 11,863,381, disposed Open Form 4 filing 0000950170-25-011239
2024-11-19 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 613,826, disposed Open Form 4 filing 0000950170-24-129455
2024-08-19 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 676,256, disposed Open Form 4 filing 0000950170-24-099275
2023-11-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 1,500,038, disposed Open Form 4 filing 0001209191-23-056012
2023-08-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,473,784, disposed Open Form 4 filing 0001209191-23-046511
2023-05-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 722,218, disposed Open Form 4 filing 0001209191-23-030599
2023-05-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,701,744, disposed Open Form 4 filing 0001209191-23-027630
2023-04-05 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,855,656, disposed Open Form 4 filing 0001209191-23-023803
2023-03-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,315,224, disposed Open Form 4 filing 0001209191-23-016059
2023-02-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 569,073, disposed Open Form 4 filing 0001209191-23-011447
2023-02-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,320,696, disposed Open Form 4 filing 0001209191-23-007376
2023-01-05 S, Open-market sale BridgeBio Pharma, Inc.BBIO 920,856, disposed Open Form 4 filing 0001209191-23-002486
2022-12-21 S, Open-market sale BridgeBio Pharma, Inc.BBIO Not reported Open Form 4 filing 0001209191-22-062377
2022-11-17 S, Open-market sale BridgeBio Pharma, Inc.BBIO 325,606, disposed Open Form 4 filing 0001209191-22-057985
2020-08-04 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 376,760, disposed Open Form 4 filing 0000899243-20-021550
2020-08-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 1,801,306, disposed Open Form 4 filing 0000899243-20-021550
2020-07-02 S, Open-market sale BridgeBio Pharma, Inc.BBIO 1,706,022, disposed Open Form 4 filing 0000899243-20-018518
2020-07-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 3 lines 2,705,335, disposed Open Form 4 filing 0000899243-20-018518
2020-06-08 S, Open-market sale BridgeBio Pharma, Inc.BBIO 318,125, disposed Open Form 4 filing 0000899243-20-015953
2020-06-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 178,173, disposed Open Form 4 filing 0000899243-20-015534
2020-06-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 2,335,390, disposed Open Form 4 filing 0000899243-20-015045
2020-05-05 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 2,469,482, disposed Open Form 4 filing 0000899243-20-012192
2020-05-04 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 1,177,685, disposed Open Form 4 filing 0000899243-20-012046
2020-05-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 1,186,400, disposed Open Form 4 filing 0000899243-20-012046
2020-04-07 S, Open-market sale BridgeBio Pharma, Inc.BBIO 45,983, disposed Open Form 4 filing 0000899243-20-010587
2020-04-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 2 lines 7,528, disposed Open Form 4 filing 0000899243-20-010359
2020-04-02 S, Open-market sale BridgeBio Pharma, Inc.BBIO 395,103, disposed Open Form 4 filing 0000899243-20-010119
2020-04-01 S, Open-market sale BridgeBio Pharma, Inc.BBIO 4 lines 1,631,362, disposed Open Form 4 filing 0000899243-20-010119
2020-03-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 394,105, disposed Open Form 4 filing 0000899243-20-006988
2020-03-03 S, Open-market sale BridgeBio Pharma, Inc.BBIO 246,365, disposed Open Form 4 filing 0000899243-20-006988

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 214
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kumar Neil, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001742485

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.